10x Genomics News

10x Genomics Analyst Ratings

BenzingaApr 18 08:12 ET

10x Genomics Analyst Ratings

BenzingaApr 10 15:37 ET

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)

TipRanksApr 10 02:51 ET

UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating

MT NewswiresFeb 21 11:52 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Travere Therapeutics (TVTX) and 10x Genomics (TXG)

TipRanksFeb 16 17:40 ET

10x Genomics Analyst Ratings

BenzingaFeb 16 09:47 ET

Stifel Nicolaus Sticks to Its Buy Rating for 10x Genomics (TXG)

TipRanksFeb 16 08:06 ET

Maintaining Buy Rating on 10x Genomics Amidst Strong Xenium Sales and Promising Future Product Launches

TipRanksFeb 16 07:20 ET

10x Genomics (TXG) Initiated With a Buy at Barclays

TipRanksFeb 16 06:58 ET

10x Genomics Poised for Growth: Buy Rating Affirmed Amid Strong Spatial Segment Performance and Solid Financial Outlook

TipRanksFeb 15 22:25 ET

10x Genomics Analyst Ratings

BenzingaJan 25 09:36 ET

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), 10x Genomics (TXG) and Altimmune (ALT)

TipRanksJan 22 14:10 ET

Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Alignment Healthcare (ALHC) and 10x Genomics (TXG)

TipRanksJan 9 05:11 ET

The Latest Analyst Ratings for 10x Genomics

BenzingaDec 14, 2023 10:00 ET

Guggenheim Initiates Coverage On 10x Genomics With Buy Rating, Announces Price Target of $60

BenzingaDec 14, 2023 05:59 ET

10x Genomics Analyst Ratings

BenzingaDec 13, 2023 12:00 ET

B of A Securities Upgrades 10x Genomics to Neutral, Raises Price Target to $54

BenzingaDec 12, 2023 07:27 ET

10x Genomics Analyst Ratings

BenzingaDec 12, 2023 07:26 ET

UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating

MT NewswiresNov 7, 2023 13:19 ET

Analysts Offer Insights on Technology Companies: DigitalOcean Holdings (DOCN), 10x Genomics (TXG) and Epam Systems (EPAM)

TipRanksNov 3, 2023 07:50 ET